Category : Type 1 Diabetes

Recent research has shed light on the importance of gut microbiota both during pregnancy and early life. Despite recent research that shows the placenta is not sterile, as previously thought, gut microbiota colonization in the first days and weeks after birth appears to have enormous significance for post-natal life, says Professor Olivier Goulet, from Hospital Necker-Enfants Malades (Paris, France). According…

GMFH Editing Team
GMFH Editing Team

Recent research has shed light on the importance of gut microbiota both during pregnancy and early life. Despite recent research that shows the placenta is not sterile, as previously thought, gut microbiota colonization in the first days and weeks after birth appears to have enormous significance for post-natal life, says Professor Olivier Goulet, from Hospital Necker-Enfants Malades (Paris, France). According…

GMFH Editing Team
GMFH Editing Team

Type 1 diabetes (T1D) incidence is increasing worldwide, with decreasing age of onset, suggesting that early-life environmental exposures may be involved. The first 3 years of life (also termed a ‘window of opportunity’) may represent the most critical period for dietary interventions aimed at gut microbiota modulation for improving child growth and development. In this context, disruption of early-life interactions…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Type 1 diabetes (T1D) incidence is increasing worldwide, with decreasing age of onset, suggesting that early-life environmental exposures may be involved. The first 3 years of life (also termed a ‘window of opportunity’) may represent the most critical period for dietary interventions aimed at gut microbiota modulation for improving child growth and development. In this context, disruption of early-life interactions…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It has been previously reported that the gut microbiota could be involved in the pathogenesis of metabolic diseases such as diabetes. A recent study, led by Dr. Wolfgang zu Castell from the Scientific Computing Research Unit at Helmholtz Zentrum München in Munich (Germany) has found that butyrate may have a protective effect in the pathogenesis of type 1 diabetes.  …

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It has been previously reported that the gut microbiota could be involved in the pathogenesis of metabolic diseases such as diabetes. A recent study, led by Dr. Wolfgang zu Castell from the Scientific Computing Research Unit at Helmholtz Zentrum München in Munich (Germany) has found that butyrate may have a protective effect in the pathogenesis of type 1 diabetes.  …

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

A long-term goal of gut microbiota research is to find a method of normalizing the microbiota early in life and sustaining it though the lifespan. Researchers from Alabama, USA, have found a method of doing this in mice. They found that cross-fostering -- giving pups to a nursing non-birth mother -- permanently shifted the pups' microbiota composition. The study examined…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A long-term goal of gut microbiota research is to find a method of normalizing the microbiota early in life and sustaining it though the lifespan. Researchers from Alabama, USA, have found a method of doing this in mice. They found that cross-fostering -- giving pups to a nursing non-birth mother -- permanently shifted the pups' microbiota composition. The study examined…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

In this paper, the first aim we had with Dr. Amandine Everard, was to investigate whether some key molecules involved in the innate immune system, mainly MyD88 [myeloid differentiation primary response gene 88], may contribute to the development of obesity, diabetes and low grade inflammation. This is not something novel, because we knew that MyD88 or Toll-like receptors are involved in…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

In this paper, the first aim we had with Dr. Amandine Everard, was to investigate whether some key molecules involved in the innate immune system, mainly MyD88 [myeloid differentiation primary response gene 88], may contribute to the development of obesity, diabetes and low grade inflammation. This is not something novel, because we knew that MyD88 or Toll-like receptors are involved in…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

I participated in the "Targeting microbiota" congress at Pasteur Institute because I considered the topics discussed very interesting and relevant to my research. For me microbiome conferences are still a rather foreign territory, but I very much like to talk to people with a very different view from what I have. And my learning curve in the microbiome field is…

Filip Scheperjans
I am German and studied medicine at the Heinrich-Heine-University in Duesseldorf, Germany and was a visiting student at the National Hospital for Neurology and Neurosurgery in London and at the Mount Sinai Medical School in New York. During my studies I started work on my doctoral theses in the C & U Vogt Brain Research Institute about the microscopical and neurochemical anatomy of the human parietal lobe. After graduating, I continued work on my thesis at the Institute of Medicine at the Research Center in Juelich. I received my doctoral degree and my thesis was awarded the best medical thesis in 2008 at Duesseldorf University. In 2007 I moved to Finland and started my clinical specialization in neurology. During this period I completed a 6 month fellowship in our clinical stroke research lab which gave me experience in the planning and conduction of clinical trials. I received my specialist degree in 2013.

I participated in the "Targeting microbiota" congress at Pasteur Institute because I considered the topics discussed very interesting and relevant to my research. For me microbiome conferences are still a rather foreign territory, but I very much like to talk to people with a very different view from what I have. And my learning curve in the microbiome field is…

Filip Scheperjans
I am German and studied medicine at the Heinrich-Heine-University in Duesseldorf, Germany and was a visiting student at the National Hospital for Neurology and Neurosurgery in London and at the Mount Sinai Medical School in New York. During my studies I started work on my doctoral theses in the C & U Vogt Brain Research Institute about the microscopical and neurochemical anatomy of the human parietal lobe. After graduating, I continued work on my thesis at the Institute of Medicine at the Research Center in Juelich. I received my doctoral degree and my thesis was awarded the best medical thesis in 2008 at Duesseldorf University. In 2007 I moved to Finland and started my clinical specialization in neurology. During this period I completed a 6 month fellowship in our clinical stroke research lab which gave me experience in the planning and conduction of clinical trials. I received my specialist degree in 2013.